Company: INDP
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001641172-25-005234
Chunk: 13

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 13
---
 but do not indicate any voting instructions, the persons named as proxies will vote the shares of common stock represented thereby for the election as Class I Directors of the persons whose names and biographies appear below. In the event that any of Mark J. Gilbert, Hila Karah, or Robert E. Martell should become unable to serve, or for good cause will not serve, as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that Mark J. Gilbert, Hila Karah, or Robert E. Martell will be unable to serve if elected. Each of Mark J. Gilbert, Hila Karah, and Robert E. Martell has consented to being named in this proxy statement and to serve if elected.

Vote required

The proposal regarding the election of directors requires the approval of a plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Class I Directors.

Votes withheld and broker non-votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal.

Recommendation of the Board of Directors

<div align='center'>The Board of Directors unanimously recommends a vote FOR the election of each of the below Class I

Director nominees.</div>

Nominees For Class I Directors (terms to expire at the 2028 Annual Meeting)

The current members of the Board of Directors who are also nominees for election to the Board of Directors as Class I Directors are as follows:

| Name                    |     | Age |     |              Served 
 as a Director Since |     | Position      
 with Indaptus |
| Mark                    
 J. Gilbert, M.D.        |     |  65 |     |                2021 |     | Director      |
| Hila                    
 Karah                   |     |  56 |     |                2021 |     | Director      |
| Robert                  
 E. Martell, M.D., Ph.D. |     |  62 |     |                2023 |     | Director      |

The principal occupations and business experience, for at least the past five years, of each Class I Director nominee for election at the Annual Meeting are as follows:

| 8 |

Mark J. Gilberthas served on our board of directors since November 2021. Dr. Gilbert brings more than 30 years